NADAV FRIEDMANN - 27 May 2022 Form 4 Insider Report for CASSAVA SCIENCES INC (SAVA)

Role
Chief Medical Officer, Director
Signature
/s/ Eric J. Schoen by Power of Attorney
Issuer symbol
SAVA
Transactions as of
27 May 2022
Transactions value $
-$655,010
Form type
4
Filing time
31 May 2022, 16:20:36 UTC
Previous filing
03 Feb 2022
Next filing
03 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAVA Common Stock Options Exercise $81.9K +3.5K +5.22% $23.38 70.6K 27 May 2022 Direct
transaction SAVA Common Stock Options Exercise $573K +24.5K +34.73% $23.38 95.1K 27 May 2022 Direct
transaction SAVA Common Stock Tax liability -$81.9K -3.07K -3.23% $26.66 92K 27 May 2022 Direct F1
transaction SAVA Common Stock Tax liability -$573K -21.5K -23.36% $26.66 70.5K 27 May 2022 Direct F1
holding SAVA Common Stock 143 27 May 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAVA Common Stock Options Exercise -$81.9K -3.5K -100% $23.38 0 27 May 2022 Common Stock 3.5K $23.38 Direct
transaction SAVA Common Stock Options Exercise -$573K -24.5K -100% $23.38 0 27 May 2022 Common Stock 24.5K $23.38 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.